ratiopharm publishes a guide for patients with tips on the proper use of drugs.

– what a drug? what are facts? or who controls the quality of generic drugs? are some questions that answer is given in the document, which will be distributed in more than 6,000 pharmacies

-the aim of this dossier is providing truthful information to the patient and assist the pharmacist in its awareness-raising efforts on the rational use of drugs

-an irrational use of medicines can lead to loss of confidence of the patient in treatment or poor results, as well as a loss of health resources

– in addition to this guide, which is intended to avoid dosing errors or adverse reactions, ratiopharm distributes other two documents with tips on healthy physical exercise and a proper diet

Madrid, March 2013– a reliable and appropriate information on the use of the drugs could prevent many mistakes in dosage, adverse drug reactions, or the development of resistance. That is why, in order to give patients an accurate and practical information, and assist the pharmacist in his work of awareness about the rational use of drugs, ratiopharm has made available Spanish pharmacies and patients an informative guide with tips on medications and their proper use.

This guide, which is presented in a question-answer format, is intended to help promote the education of the patient on a subject as broad as the drug. Since the beginning of this year, ratiopharm will distribute more than 4,000 copies between pharmacies, to make the pharmacist that put it at the disposal of the patient.

what is a medicament? how do? from what are made? They are some of the questions that Dr. Nancy single Uthurry pharmacy (member of the Executive Committee of the Pharmaceutical Care Spain Foundation and of the Scientific Committee of the SEFAC) responds in this information, with data Pack as that medicine can be manufactured with substances man-made or produced by other organismssuch as digoxin, which is used to treat heart conditions and is extracted from a plant. In addition, this expert also clears doubts about the case of generic drugs, from who controls the quality of them, up to what benefit a country’s economy.

The irrational use of drugs can lead to loss of confidence of the patient in treatment due to the bad results obtained, as well as constituting a loss of valuable health resources ”, are running from ratiopharm. At the same time highlighted that the pharmacist is the link between the drug and the patient, and therefore a key referent, since it can provide people reliable knowledge and practical about the drugs helping to interpret the leaflet, to clarify dosage, to underline the dangers of self-medication, or medications to keep ”.

You manage your health

This guide also contains a series of practical tips to help each patient to manage properly their health in relation to drugs. On the one hand, emphasis on the necessary knowledge of the appropriate dose of each drug, for which the patient can and you should consult your pharmacist. On the other hand, it highlights the role of the pharmacist as an agent of inquiry of possible interactions and adverse reactions, causes important hospital admissions and emergency room visits. In this regard, it highlights is the importance of the pharmacist in the increase of safety of the treatment, as well as a correct recycling of drugs.

About ratiopharm

ratiopharm S.A.U is a pharmaceutical company specializing in the production and marketing of generic drugs. ratiopharm markets a wide range of molecules belonging to the most important therapeutic areas, making it one of the laboratories of generics more important in Europe. With more than 900 registered preparations, ratiopharm has one of the portfolios more extensive in the field of generic drugs, covering almost all therapeutic areas. It belongs to the TEVA Group (NYSE:TEVA), a leading pharmaceutical company globally committed to improving access to health care to developing, producing and marketing generic medicines, as well as innovative drugs and pharmaceutical specialities.